ANAB · Forms 3, 4, 5
Insider trades at ANAPTYSBIO, INC
1 insider sold $249K of ANAPTYSBIO, INC stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for ANAPTYSBIO, INC (ANAB) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Hollings Renton | Director | Option exercise | 5,000 | $18.03 | $90K | Form 4 | |
| Hollings Renton | Director | Sell (10b5-1 plan) | 5,000 | $49.87 | $249K | Form 4 | |
| John A Orwin | Director | Option exercise | 1,300 | Form 4 | |||
| Paul F. Lizzul | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Daniel Faga | President, CEO | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.